论文信息 - Final Overall Survival Analysis of the TOURMALINE-MM1 Phase III Trial of Ixazomib, Lenalidomide, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma - 字舞流文

Final Overall Survival Analysis of the TOURMALINE-MM1 Phase III Trial of Ixazomib, Lenalidomide, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma

P. Ganly | J. Laubach | P. Richardson | Shaji K. Kumar | P. Moreau | C. Touzeau | T. Masszi | M. Hansson | F. Buadi | P. Gimsing | M. Cavo | L. Garderet | A. Stoppa | N. Bahlis | L. Pour | D. Berg | M. Darif | I. Sandhu | S. Jackson | N. Grzasko | B. Baker | R. Labotka